BR112022013296A2 - Composição para uso no tratamento de transtornos cognitivos - Google Patents
Composição para uso no tratamento de transtornos cognitivosInfo
- Publication number
- BR112022013296A2 BR112022013296A2 BR112022013296A BR112022013296A BR112022013296A2 BR 112022013296 A2 BR112022013296 A2 BR 112022013296A2 BR 112022013296 A BR112022013296 A BR 112022013296A BR 112022013296 A BR112022013296 A BR 112022013296A BR 112022013296 A2 BR112022013296 A2 BR 112022013296A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- cognitive disorders
- composition
- compositions
- relates
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000000284 extract Substances 0.000 abstract 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 abstract 1
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 abstract 1
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 abstract 1
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 abstract 1
- DSCFFEYYQKSRSV-HMSOCMLXSA-N D-pinitol Natural products CO[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-HMSOCMLXSA-N 0.000 abstract 1
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 229940096998 ursolic acid Drugs 0.000 abstract 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
- A61K31/75—Polymers of hydrocarbons of ethene
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1868—Docosahexaenoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
COMPOSIÇÃO PARA USO NO TRATAMENTO DE TRANSTORNOS COGNITIVOS. A invenção refere-se a composições de origem natural que são úteis no tratamento de transtornos cognitivos que contêm D-pinitol e ácido ursólico ou extratos de fontes naturais que são enriquecidos nestes componentes e que podem compreender, adicionalmente, DHA e/ou um extrato de Ginkgo biloba. A invenção também se refere ao uso dessas composições para o tratamento de transtornos cognitivos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES2020070005 | 2020-01-03 | ||
PCT/EP2021/050270 WO2021136848A1 (en) | 2020-01-03 | 2021-01-08 | Composition for use in the treatment of cognitive disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022013296A2 true BR112022013296A2 (pt) | 2022-09-06 |
Family
ID=69941402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022013296A BR112022013296A2 (pt) | 2020-01-03 | 2021-01-08 | Composição para uso no tratamento de transtornos cognitivos |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP4084787A1 (pt) |
JP (1) | JP2023510525A (pt) |
KR (1) | KR20220123272A (pt) |
CN (1) | CN115066237A (pt) |
AU (1) | AU2021204964A1 (pt) |
BR (1) | BR112022013296A2 (pt) |
CO (1) | CO2022010461A2 (pt) |
MX (1) | MX2022008258A (pt) |
WO (1) | WO2021136848A1 (pt) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540884A (en) | 1982-12-29 | 1985-09-10 | Finnigan Corporation | Method of mass analyzing a sample by use of a quadrupole ion trap |
US5397894A (en) | 1993-05-28 | 1995-03-14 | Varian Associates, Inc. | Method of high mass resolution scanning of an ion trap mass spectrometer |
US7112609B2 (en) | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
US6258846B1 (en) | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
ES2179767B1 (es) | 2001-03-16 | 2004-05-16 | Compañia General Del Algarrobo De España, S.A. | Procedimiento para la obtencion de pinitol a partir de extractos de algarroba. |
US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
PT1559430E (pt) * | 2004-01-29 | 2009-06-16 | Indena Spa | Utilização de complexos de ginkgo para potenciar as funções cognitivas e aliviar a fadiga mental |
HUE041715T2 (hu) * | 2007-12-21 | 2019-05-28 | Dr Willmar Schwabe Gmbh & Co Kg | Ginkgo biloba levél-kivonat alkalmazása |
EP2087900A1 (en) * | 2008-02-07 | 2009-08-12 | Velleja Research SRL | Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antogonist terpenic fraction, and compostions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders |
EP2627326A2 (en) * | 2010-10-12 | 2013-08-21 | Vifor SA | Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
US20150164833A1 (en) * | 2013-12-17 | 2015-06-18 | Mead Johnson Nutrition Company | Nutritional composition containing a neurologic component of ursolic acid and uses thereof |
-
2021
- 2021-01-08 MX MX2022008258A patent/MX2022008258A/es unknown
- 2021-01-08 CN CN202180008005.7A patent/CN115066237A/zh active Pending
- 2021-01-08 AU AU2021204964A patent/AU2021204964A1/en active Pending
- 2021-01-08 KR KR1020227026367A patent/KR20220123272A/ko unknown
- 2021-01-08 BR BR112022013296A patent/BR112022013296A2/pt unknown
- 2021-01-08 JP JP2022541278A patent/JP2023510525A/ja active Pending
- 2021-01-08 EP EP21700015.7A patent/EP4084787A1/en active Pending
- 2021-01-08 WO PCT/EP2021/050270 patent/WO2021136848A1/en active Application Filing
-
2022
- 2022-07-26 CO CONC2022/0010461A patent/CO2022010461A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2022010461A2 (es) | 2022-08-09 |
MX2022008258A (es) | 2022-08-11 |
EP4084787A1 (en) | 2022-11-09 |
KR20220123272A (ko) | 2022-09-06 |
WO2021136848A1 (en) | 2021-07-08 |
AU2021204964A1 (en) | 2022-07-07 |
CN115066237A (zh) | 2022-09-16 |
JP2023510525A (ja) | 2023-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019000427A (es) | Formas de dosificacion oral de cannabinoide de alta concentracion. | |
MA46990B1 (fr) | Compositions glp-1 et ses utilisations | |
BR112017026586A2 (pt) | composições de terapia de restauração de microbiota (mrt) e métodos de fabricação | |
CL2017001983A1 (es) | Composiciones farmacéuticas para terapia combinada. | |
ZA201805792B (en) | Taurine and aloe synergistic anti-irritant compositions and methods | |
BR112018069876A2 (pt) | composição cosmética, método para fotoestabilização de resveratrol, polidatina, ou uma mistura dos mesmos com baicalina e método | |
MY155710A (en) | Composition for regulating lipid metabolism | |
BR112018016307A2 (pt) | usos de composição e de produto, método de combate a maus odores e composição | |
BR112019018088A2 (pt) | Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados | |
BR0317420A (pt) | Luva tratada com camomila/aloe vera | |
BR112022019614A2 (pt) | Dispersões de poliuretano de base biológica para aplicações cosméticas decorativas | |
BR112016026660A2 (pt) | ?produto extemporâneo para cuidados cosméticos e/ou dermatológicos, e, kit de preparação extemporânea de uma composição cosmética e/ou dermatológica? | |
BR112022013296A2 (pt) | Composição para uso no tratamento de transtornos cognitivos | |
CL2019000174A1 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d. | |
BR112015023368A2 (pt) | método de tratamento de deficiência de vitamina b12 | |
BR112023024034A2 (pt) | Polipeptídeos de sars-cov-2 | |
NO20061223L (no) | Orale sammensetninger for behandlingen av cellulitt | |
FR3098713B1 (fr) | Nanoparticules d’or comprenant un extrait de plantes et leur utilisation cosmetique | |
MX2021010219A (es) | Composicion para uso en la prevencion y/o tratamiento de la disbiosis. | |
BR112015024792A2 (pt) | métodos para a fabricação de uma composição cosmética, para a aplicação da fragrância e de alcançar um benefício antitranspirante | |
BR112018071493A2 (pt) | usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce | |
BRPI0601496A (pt) | composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas | |
TR202016869A1 (tr) | Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu | |
MX2018003120A (es) | Crema para el mejoramiento de la piel con arrugas. | |
BR112018075252A2 (pt) | gordura de carne bovina em pó |